Elevance Book Value Per Share from 2010 to 2024

ELV Stock

USD 538.94 2.10 0.39%

Elevance Health Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Elevance Health according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

166.62144977

Current Value

174.95

Quarterly Volatility

43.16690561

Credit Downgrade

Yuan Drop

Covid

Check Elevance Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevance Health's main balance sheet or income statement drivers, such as Interest Expense of 1.1 B, Total Revenue of 179.9 B or Gross Profit of 161.7 B, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0153 or PTB Ratio of 1.5. Elevance financial statements analysis is a perfect complement when working with Elevance Health Valuation or Volatility modules.

Check out the analysis of Elevance Health Correlation against competitors.

For more information on how to buy Elevance Stock please use our How to Invest in Elevance Health guide.

Latest Elevance Health's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Elevance Health over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Elevance Health's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevance Health's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 174.62 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Elevance Book Value Per Share Regression Statistics

	Arithmetic Mean	108.42
	Geometric Mean	93.30
	Coefficient Of Variation	39.81
	Mean Deviation	33.41
	Median	103.49
	Standard Deviation	43.17
	Sample Variance	1,863
	Range	167
	R-Value	0.96
	Mean Square Error	164.84
	R-Squared	0.92
	Slope	9.25
	Total Sum of Squares	26,087

Elevance Book Value Per Share History

	2024	174.95
	2023	166.62
	2022	151.28
	2021	147.91
	2020	132.37
	2019	124.18
	2018	112.23

Other Fundumenentals of Elevance Health

Tangible Book Value Per Share

Elevance Health Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Intangible Assets	Property Plant Equipment	Net Receivables	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Good Will	Deferred Long Term Liab	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Capital Stock
Total Assets		0.99	0.93	0.84	0.81	0.79	0.98	0.98	0.9	0.76	0.76	0.75	0.58	0.09	0.77	0.98	0.43	0.2	0.94	-0.7	0.59	0.0	0.67	0.68	-0.58
Total Stockholder Equity	0.99		0.92	0.84	0.8	0.76	0.96	0.97	0.94	0.74	0.73	0.71	0.6	0.23	0.82	0.98	0.44	0.15	0.91	-0.69	0.53	-0.04	0.61	0.63	-0.52
Net Debt	0.93	0.92		0.73	0.68	0.68	0.97	0.87	0.89	0.6	0.61	0.62	0.63	0.19	0.74	0.95	0.59	0.01	0.82	-0.7	0.39	0.13	0.42	0.45	-0.38
Total Liab	0.84	0.84	0.73		0.98	0.97	0.82	0.81	0.81	0.96	0.96	0.95	0.47	0.04	0.84	0.87	0.43	0.33	0.9	-0.85	0.82	0.02	0.69	0.83	-0.77
Retained Earnings	0.81	0.8	0.68	0.98		0.97	0.78	0.77	0.73	0.99	0.99	0.96	0.5	-0.04	0.76	0.82	0.32	0.47	0.91	-0.82	0.85	-0.02	0.73	0.88	-0.8
Accounts Payable	0.79	0.76	0.68	0.97	0.97		0.78	0.74	0.7	0.97	0.97	0.99	0.4	-0.12	0.75	0.8	0.44	0.45	0.87	-0.84	0.84	0.02	0.72	0.86	-0.79
Long Term Debt	0.98	0.96	0.97	0.82	0.78	0.78		0.93	0.89	0.72	0.72	0.74	0.58	0.1	0.76	0.98	0.53	0.16	0.9	-0.73	0.51	0.08	0.59	0.59	-0.5
Short Term Investments	0.98	0.97	0.87	0.81	0.77	0.74	0.93		0.89	0.73	0.72	0.7	0.49	0.08	0.77	0.94	0.4	0.17	0.93	-0.63	0.59	-0.03	0.7	0.69	-0.6
Intangible Assets	0.9	0.94	0.89	0.81	0.73	0.7	0.89	0.89		0.65	0.64	0.63	0.5	0.43	0.91	0.95	0.58	-0.13	0.79	-0.7	0.44	0.04	0.41	0.47	-0.41
Property Plant Equipment	0.76	0.74	0.6	0.96	0.99	0.97	0.72	0.73	0.65		0.99	0.97	0.41	-0.13	0.71	0.76	0.28	0.53	0.88	-0.76	0.89	-0.03	0.78	0.93	-0.84
Net Receivables	0.76	0.73	0.61	0.96	0.99	0.97	0.72	0.72	0.64	0.99		0.98	0.46	-0.16	0.71	0.75	0.28	0.5	0.88	-0.82	0.89	0.01	0.76	0.91	-0.84
Total Current Assets	0.75	0.71	0.62	0.95	0.96	0.99	0.74	0.7	0.63	0.97	0.98		0.37	-0.19	0.69	0.75	0.42	0.51	0.85	-0.79	0.86	0.0	0.76	0.89	-0.82
Short Term Debt	0.58	0.6	0.63	0.47	0.5	0.4	0.58	0.49	0.5	0.41	0.46	0.37		0.11	0.34	0.59	0.01	0.13	0.58	-0.48	0.31	-0.2	0.21	0.31	-0.28
Common Stock	0.09	0.23	0.19	0.04	-0.04	-0.12	0.1	0.08	0.43	-0.13	-0.16	-0.19	0.11		0.48	0.21	0.22	-0.56	-0.08	-0.13	-0.44	0.0	-0.39	-0.4	0.5
Current Deferred Revenue	0.77	0.82	0.74	0.84	0.76	0.75	0.76	0.77	0.91	0.71	0.71	0.69	0.34	0.48		0.84	0.57	-0.11	0.72	-0.82	0.46	0.17	0.4	0.48	-0.41
Good Will	0.98	0.98	0.95	0.87	0.82	0.8	0.98	0.94	0.95	0.76	0.75	0.75	0.59	0.21	0.84		0.54	0.11	0.91	-0.76	0.54	0.04	0.56	0.61	-0.52
Deferred Long Term Liab	0.43	0.44	0.59	0.43	0.32	0.44	0.53	0.4	0.58	0.28	0.28	0.42	0.01	0.22	0.57	0.54		-0.14	0.26	-0.41	0.14	0.13	0.05	0.11	-0.12
Net Tangible Assets	0.2	0.15	0.01	0.33	0.47	0.45	0.16	0.17	-0.13	0.53	0.5	0.51	0.13	-0.56	-0.11	0.11	-0.14		0.35	-0.11	0.52	-0.33	0.57	0.64	-0.49
Long Term Debt Total	0.94	0.91	0.82	0.9	0.91	0.87	0.9	0.93	0.79	0.88	0.88	0.85	0.58	-0.08	0.72	0.91	0.26	0.35		-0.74	0.76	0.0	0.8	0.84	-0.75
Capital Surpluse	-0.7	-0.69	-0.7	-0.85	-0.82	-0.84	-0.73	-0.63	-0.7	-0.76	-0.82	-0.79	-0.48	-0.13	-0.82	-0.76	-0.41	-0.11	-0.74		-0.56	-0.35	-0.42	-0.54	0.5
Long Term Investments	0.59	0.53	0.39	0.82	0.85	0.84	0.51	0.59	0.44	0.89	0.89	0.86	0.31	-0.44	0.46	0.54	0.14	0.52	0.76	-0.56		-0.06	0.76	0.95	-0.99
Short Long Term Debt	0.0	-0.04	0.13	0.02	-0.02	0.02	0.08	-0.03	0.04	-0.03	0.01	0.0	-0.2	0.0	0.17	0.04	0.13	-0.33	0.0	-0.35	-0.06		-0.11	-0.11	0.07
Cash And Equivalents	0.67	0.61	0.42	0.69	0.73	0.72	0.59	0.7	0.41	0.78	0.76	0.76	0.21	-0.39	0.4	0.56	0.05	0.57	0.8	-0.42	0.76	-0.11		0.89	-0.79
Net Invested Capital	0.68	0.63	0.45	0.83	0.88	0.86	0.59	0.69	0.47	0.93	0.91	0.89	0.31	-0.4	0.48	0.61	0.11	0.64	0.84	-0.54	0.95	-0.11	0.89		-0.95
Capital Stock	-0.58	-0.52	-0.38	-0.77	-0.8	-0.79	-0.5	-0.6	-0.41	-0.84	-0.84	-0.82	-0.28	0.5	-0.41	-0.52	-0.12	-0.49	-0.75	0.5	-0.99	0.07	-0.79	-0.95

Click cells to compare fundamentals

About Elevance Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Elevance Health income statement, its balance sheet, and the statement of cash flows. Elevance Health investors use historical funamental indicators, such as Elevance Health's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Elevance Health investors may use each financial statement separately, they are all related. The changes in Elevance Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Elevance Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Elevance Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Elevance Health. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	166.62	174.95
Tangible Book Value Per Share	16.17	16.98

Pair Trading with Elevance Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elevance Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevance Health will appreciate offsetting losses from the drop in the long position's value.

Moving against Elevance Stock

0.7	SDGR	Schrodinger	Pair Corr
0.67	PGNY	Progyny	Pair Corr
0.67	TDOC	Teladoc	Pair Corr
0.66	AMWL	American Well Corp	Pair Corr
0.65	DRUG	Bright Minds Biosciences	Pair Corr

The ability to find closely correlated positions to Elevance Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elevance Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elevance Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elevance Health to buy it.

The correlation of Elevance Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elevance Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elevance Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Elevance Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Elevance Stock Analysis

When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC